Global third-party due diligence: Balancing AI-driven automation with human intelligence

What life sciences professionals need to know 

Effectively managing third-party risk due diligence remains a critical component of effective risk management for life sciences organizations. As the industry continues to embrace greater automation, AI tools have significantly improved the process allowing technology to process large amounts of data and better quantify risks. The challenge of maintaining thorough due diligence while remaining thoughtful in the use of technology vs human-driven due diligence remains critical.

Join Baker Tilly and TDI for an informative webinar where we will explore the evolving landscape of third-party due diligence in life sciences. In this webinar we will discuss the impact of the rapidly evolving technology landscape and highlight the crucial role human intelligence plays in the process. Key topics will include: 

• Success factors and limitations of due diligence technology 
• Key triggers and essential components for human-driven due diligence 
• The importance of a multi-disciplinary approach, combining expertise in compliance, financial controls and reputational risk 
• Effectively leveraging local insights in high-risk markets and regions 

Who should attend 

• C-Suite professionals, presidents, vice presidents, management and other leaders of life sciences organizations

Presenters 

• Darren Jones, Principal, Life sciences industry leader, Baker Tilly 
• Mario Prohasky, Director, Baker Tilly 
• David Fisher, President, TDI